Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Lee HY, Min KW, Han KA, Kim JS, Ahn JC, Kim MH, Lee JB, Shin SH, Kim CJ, Kim KH, Cho DK, Choi J, Rhee MY, Her SH, Kim W, Na JO, Cho GY, Kim SY, Park GM, Lee BK, Jo SH, Lee BW, Sohn IS, Kim DI, Ihm SH, Lee SH, Chung JW, Cho EJ, Son JW, Oh SJ, Hwang JY, Jeong JO, Han KR, Yoon HJ, Seo SM, Chung WJ, Bae JW, Choi JH, Hyun BJ, Cha JE, Yoo SJ, Shin J. Lee HY, et al. Among authors: kim cj. Clin Ther. 2024 May 3:S0149-2918(24)00084-5. doi: 10.1016/j.clinthera.2024.04.004. Online ahead of print. Clin Ther. 2024. PMID: 38704294
Optimal timing of percutaneous coronary intervention for non-ST elevated myocardial infarction with congestive heart failure.
Lim Y, Kim MC, Ahn JH, Lee SH, Hyun DY, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Choi IJ, Choo EH, Lim S, Hwang BH, Park MW, Kim CJ, Park CS, Kim HY, Chang K, Ahn Y. Lim Y, et al. Among authors: kim cj. Cardiovasc Revasc Med. 2024 Apr 25:S1553-8389(24)00447-0. doi: 10.1016/j.carrev.2024.04.295. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38679500
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Lee SH, Oh S, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Jeong YH, Park Y, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Lee JH, Yoo SY, Ahn Y; OPTION-STEMI Investigators Gwangju, Korea; Suncheon, Korea; Jeonju, Korea; Seoul, Korea; Jinju, Korea; Wonju, Korea; Gwangmyeong, Korea; Changwon, Korea; Bucheon, Korea; Uijeongbu, Korea; Daegu, Korea; Pyeongtaek, Korea; Gangneung, Korea. Kim MC, et al. Among authors: kim cj. Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.03.017. Online ahead of print. Am Heart J. 2024. PMID: 38641031 Free article.
2,429 results